High levels of TGFβ-activated kinase 1 (TAK1) in AML CD34+ cells compared to normal cells suggest that the pro-survival functions of NF-κB are also mediated by TAK1 [84]. The gene discussed is NFKB1; the disease is acute myeloid leukemia.